Assessing visual functions in infants at risk of visual impairment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate visual function in infants from neonatal age up to 36 months who are at risk of developing visual impairment due to brain lesions or ocular pathologies. The study will monitor these infants to identify early signs of visual impairment and understand the progression of their visual capabilities. By focusing on a specific age group and risk factors, the study seeks to gather valuable data that could inform future interventions and support for affected children.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age
* Genetic syndroms
* Hypoxic Hischemic Encephalopathy
* Brain malformation
* Metabolic diseases
* Ocular pathologies

Exclusion Criteria:

* Patients at low risk of developing neurological outcomes
* Refusal of informed consent

Where it's running

• Fondazione Policlinico Gemelli
  Rome, Italy Recruiting

Study contacts

• Study coordinator: Daniela Ricci, Medical Doctor
• Email: d.ricci@iapb.it
• Phone: +393929477842

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive behavioral therapy plus mindfulness program to help people adjust to vision loss

  This project will try an 8-week group program combining cognitive behavioral therapy and mindfulness for adults adjusting to vision loss.

  Recruiting The Chicago Lighthouse · Chicago, Illinois · NCT07073521

• Easy-to-Read Visual Health Materials for Children and Teens with Intellectual Disabilities

  This program will try easy-to-read and audio-based eye health materials plus a digital screening tool to improve visual health for children and adolescents with intellectual disabilities.

  Recruiting National Taiwan University Hospital · Taipei · NCT07036575

• Blood and OCT biomarkers in people with diabetic macular edema receiving anti-VEGF or dexamethasone implant

  This project will test whether blood markers and OCT imaging signs can predict how people with diabetic macular edema respond to anti-VEGF injections or a dexamethasone eye implant.

  Recruiting Vastra Gotaland Region · Mölndal and 1 other locations · NCT06984822

• Michigan telemedicine screening for glaucoma and other sight‑threatening eye problems

  This program tests whether a technology-enhanced telemedicine screening finds glaucoma, diabetic eye disease, and visually significant cataracts more often than a standard optometric exam for patients at a community health center.

  Recruiting University of Michigan · Flint, Michigan · NCT06934577

• Assessing visual frailty in older adults with age-related macular degeneration

  This study is trying to see if a new tool can help understand how vision problems affect older adults with advanced age-related macular degeneration and their overall health.

  Recruiting University of Edinburgh · Edinburgh, Scotland and 1 other locations · NCT06604104

• Understanding how Giant Cell Arteritis affects vision

  This study is trying to understand how Giant Cell Arteritis affects vision in adults by comparing eye health in those with GCA-related vision problems to those with other causes of vision loss.

  Recruiting ASST Fatebenefratelli Sacco · Milan, Lombardy · NCT06500728

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.